Bioweapons: When diseases become a weapon

Advances in biotechnology and artificial intelligence introduce concerns regarding the potential misuse of scientific knowledge for biological weapons development. Experts note that AI's capacity to process large datasets rapidly could be leveraged for more precise analysis and modification of pathogens, creating a long-term risk for biological weapon development. Security agencies have expressed concern that artificial intelligence could increase danger from existing or new biological weapons, particularly in the hands of non-state actors.
The debate centers on the difficulty in separating legitimate scientific research from potential military or malicious applications, exemplified by attempts to use AI in Gain-of-Function research related to pathogens like avian flu variants. Biological weapons involve a biological agent and a delivery mechanism, causing infectious diseases, which differentiates them from chemical weapons that cause immediate toxicity. While biological weapons are internationally prohibited under the Biological Weapons Convention, control mechanisms are less developed than for chemical weapons, leading to reliance on transparency rather than inspection.
The difficulty in detection stems from the dual-use nature of many technologies; laboratory equipment used for medicine can also be used for military research, and biological attacks can mimic natural outbreaks, complicating attribution.

* Artificial intelligence could be misused for the development of biological weapons.
* Advances in biotechnology allow for more precise analysis and modification of pathogens.
* AI can process large amounts of data more quickly.
* The head of MI5 warned that artificial intelligence could increase danger from biological weapons in the future, including those by non-state actors.
* Anthropic's report detected and blocked research attempts using Claude related to potential biological weapons, including Gain-of-Function research and avian flu variant investigation.
* Research on pathogens can serve both medical precautions and military purposes.
* Biological weapons consist of a biological agent (e.g., viruses or bacteria) and a delivery mechanism (e.g., rockets or spray systems).
* Biological weapons are grouped with chemical and nuclear weapons as weapons of mass destruction.
* Chemical weapons cause immediate toxicity, while biological weapons cause infectious diseases that can spread person-to-person over hours, days, or weeks.
* The Biological Weapons Convention (BWC), established in 1975, prohibits the development, production, storage, transfer, and use of biological and toxin-based weapons.
* The Chemical Weapons Convention is monitored by the Organisation for the Prohibition of Chemical Weapons (OPCW).
* Control over biological weapons is based on transparency, voluntary reporting, and international trust rather than comprehensive inspection systems.

The tension highlighted in this information lies at the intersection of scientific capability and international governance. The core difficulty is not just preventing the physical deployment of agents but managing the inherent ambiguity introduced by dual-use research, where the same tools for medical advancement and weaponization coexist. The challenge in controlling biological threats is compounded because detection relies on post-event investigation—determining whether an outbreak was natural or deliberate—which inherently delays effective response and accountability.
The structure of international control reveals a fundamental asymmetry: chemical weapons have established monitoring mechanisms via the OPCW, whereas biological weapons lack comparable systems. This absence means that control over biological threats remains heavily reliant on state trust and voluntary adherence to conventions, creating systemic vulnerabilities when actors operate outside formal oversight. The fear is amplified by the potential for sophisticated agents—AI-enhanced research—to blur the lines between legitimate scientific pursuit and malicious intent, pushing the risk profile into unpredictable territory where 'natural' disease outbreaks can be intentionally manipulated to conceal malicious origins.
What questions remain open regarding this dynamic are: If research environments are inherently dual-use, what verifiable, real-time safeguards can be implemented to separate innocent inquiry from weaponization? How can international frameworks evolve to mandate the transparency necessary for control when empirical evidence is deliberately obscured by the nature of the threat itself? And what responsibilities do institutions hold in mitigating the risk posed by rapidly evolving dual-use technologies that are being leveraged by non-state actors?